Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Brain Injuries
Diseases [C] » Nervous System Diseases [C10] » Trauma, Nervous System » Craniocerebral Trauma » Brain Injuries
Diseases [C] » Wounds and Injuries [C26] » Trauma, Nervous System » Craniocerebral Trauma » Brain Injuries
Description
Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. MeSH
Hierarchy View
Subtype Terms (8)
Brain Injuries, Traumatic
183 drugs (124 approved, 59 experimental)
Brain Injury, Chronic
3 drugs (2 approved, 1 experimental)
Epilepsy, Post-Traumatic
5 drugs (4 approved, 1 experimental)
Pneumocephalus
1 approved drug
Post-Cardiac Arrest Syndrome
12 approved drugs
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (25)
Phase 3 Indicated Drugs (6)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (23)
Organization Involved with Phase 4 Indications (79)
Mayfield Clinic & Spine Institute
Methodist Rehabilitation Center
National Center for Research Resources (NCRR)
National Institutes of Health (NIH)
Ontario Mental Health Foundation
Ontario Neurotrauma Foundation
Ospedale Maggiore San Giovanni Bosco
Shaanxi Provincial People's Hospital
Shahid Beheshti University of Medical Sciences
Swiss National Science Foundation
The First People's Hospital of Lianyungang
The University of Texas, Dallas
Organization Involved with Phase 3 Indications (100)
Australian and New Zealand Intensive Care Society Clinical Trials Group
Canadian Department of National Defense
Canadian Institutes of Health Research (CIHR)
Cristália Produtos Químicos Farmacêuticos Ltda.
Defence Research and Development Canada
Direction Centrale du Service de Santé des Armées
Fondo de Investigacion Sanitaria
Health Research Board, Ireland
Health Research Council, New Zealand
Hospital Universitari Son Dureta
Institut d'Anesthesiologie des Alpes Maritimes
Institut National de la Santé Et de la Recherche Médicale, France
Irish Critical Care Clinical Trials Network
JP Moulton Charitable Foundation
Katholieke Universiteit Leuven
Medical Research Future Fund (MRFF)
Moss Rehabilitation Research Institute
National Health and Medical Research Council, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Neurological Disorders and Stroke (NINDS)
National University of Ireland
Neurological Emergencies Treatment Trials Network
Pediatric Emergency Care Applied Research Network
Pharmaceutical Research Associates, Inc. (PRA)
Polish Mother Memorial Hospital Research Institute
Organization Involved with Phase 2 Indications (79)
Center for Neurological Studies (CNS)
Eastern Association for the Surgery of Trauma
HonorHealth Research Institute
International Brain Research Foundation
Lieber Institute for Brain Development (LIBD)
Mashhad University of Medical Sciences
National Institute of Nursing Research (NINR)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Neuren Pharmaceuticals Limited
Oregon Health and Science University
Rehabilitation Hospital of Indiana
South East Sydney and Illawarra Area Health Service
Uniformed Services University of Health Sciences
Uniformed Services University of the Health Sciences
Organization Involved with Phase 1 Indications (32)
Children's Medical Center Dallas
Chinese Academy of Medical Sciences
Guangdong Women and Children Hospital
Harch Hyperbaric Research Foundation
Lakeland Regional Medical Center
Organization Involved with Other Experimental Indications (31)
Harborview Injury Prevention and Research Center
Kessler Institute for Rehabilitation
Laureate Institute for Brain Research
Mary Free Bed Rehabilitation Hospital
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
